期刊文献+

RNAi抑制食管癌细胞Eca-109中OGT的表达研究

RNAi inhibitting the expression of OGT in esophagel cancer cells Eca-109
下载PDF
导出
摘要 目的:研究RNAi表达载体对食管癌细胞Eca-109中OGT基因表达的抑制作用。方法:构建针对OGT基因的干扰载体,用质粒转染食管癌细胞Eca-109,RT-PCR分析干扰载体对OGT基因的抑制情况,Western blot分析干扰后OGT蛋白的表达情况。结果:OGT基因在食管癌细胞Eca-109中高表达,三个干扰序列中瞬时转染干扰载体RNAi-OGTB-Eca109的干扰效率最高,可达80%。稳转干扰OGT蛋白水平抑制率65.21%,与对照组相比有统计学意义(P<0.05),O-GlcNAc水平下降(RL2反映)率37.5%,与对照组相比有统计学意义(P<0.05)。结论:用RNAi表达载体可以有效抑制食管癌细胞Eca-109中OGT基因的表达。 Objective:To investigate the inhibitory effects of RNAi expression vector on the expression of OGT in esophagel cancer cell Eca - 109. Methods:The expression of OGT in esophagel cancer cell Eca - 109 was examined with RT - PCR and Western blot. At the same time, the RNAi expression vectors aimed OCT were constructed and transfected into Eca - 109 cells with plasmids. The expression of OGT mRNA was detected with RT - PCR and the expression of OGT protein was detected with Western blot. Results:There was a high expression of OGT in Eca - 109 ceils. The expression of OGT gene was inhibited about 80% by RNAi - OGTB in transient transfection Eca - 109 ceils. The expression of OGT protein was inhibited about 50.6% in stable transfection Eca - 109 cells ,and there was a significant difference compared with control group (P 〈 0.05 ). The level of O- GIcNAc decreased 37.5% in the interfered group compared with control group and there was significant difference ( P 〈 0.05 ). Conclusion: The RNAi expression vector can effectively inhibit the expression of OGT gene in esophagel cancer cell Eca- 109 cells.
出处 《现代肿瘤医学》 CAS 2014年第7期1544-1549,共6页 Journal of Modern Oncology
关键词 RNA干扰 食管癌 氧连接氮乙酰氨基葡萄糖转移酶 RNAi esophagel cancer OGT
  • 相关文献

参考文献13

  • 1Torres CR,Hart GW.Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes.Evidence for O-linked GlcNAc[J].Biol Chem,1984,259:3308-3317.
  • 2Hart GW,Housley MP,Slawson C.Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins[J].Nature,2007,446:1017-1022.
  • 3Love DC,Hanover JA.The hexosamine signaling pathway:deciphering the "O-GlcNAc code"[J].Sci STKE,2005,2005:re13.
  • 4Haltiwanger RS,Holt GD,Hart GW.Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins.Identification of a undine diphospho-A-acetylglucosamine:Peptide β-N-acetylglucosa minyltransferase[J].Biol Chem,1990,265:2563-2568.
  • 5Shi Y,Tomic J,Wen F,et al.Aberrant O-GlcNAcylation characterizes chronic lymphocytic leukemia[J].Leukemia,2010,24(9):1588-1598.
  • 6Mi W,Gu Y,Han C,et al.O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy[J].Biochim Biophys Acta,2011,1812:514-519.
  • 7Caldwell SA,Jackson SR,Shahriari KS,et al.Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1[J]. Oncogene,2010,29(19):2831-2834.
  • 8Qianqian Zhu,Lin Zhou,Zhe Yang,et al.O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation[J].Med Oncol,2012,29(2):985-993.
  • 9Bech-Otschir D,Kraft R,Huang X,et al.COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system[J].EMBO,2001,20:1630-1639.
  • 10Yang WH,Kim JE,Nam HW,et al.Modification of p53 with O-linked N acetylglucosamine regulates p53 activity and stability[J].Nature Cell Biol,2006,8:1074-1083.

二级参考文献32

  • 1Zeidan Q, Hart GW. The intersections between O-Glc- NAcylation and phosphorylation: implications for mul- tiple signaling pathways. J Cell Sci 2010; 123: 13-22.
  • 2Marshall S, Bacote V, Traxinger RR. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991; 266: 4706-12.
  • 3Copeland RJ, Bullen JW, Hart GW. Cross-talk between GlcNAcylation and phosphorylation: roles in insulin re- sistance and glucose toxicity. Am J Physiol Endocrinol Metab 2008; 295: E17-E28.
  • 4Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematicreview and meta-analysis. J Am Med Assoc 2008; 300: 2754-64.
  • 5Torres CR, Hart GW. Topography and polypeptide dis- tribution of terminal N-acetylglucosamine residues on thesurfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 1984; 259: 3308-17.
  • 6Hart GW, Housley MP, Slawson C. Cycling of O-linked 13-N-acetylglucosamine on nucleocytoplasmic proteins. Nature 2007; 446: 1017-22.
  • 7Housley MP, Rodgers JT, Udeshi ND, Kelly TJ, Shaba- nowitz J, Hunt DF, et al. O-GlcNAc regulates Foxo ac- tivation in response to glucose. J Biol Chem 2008; 283: 16283-92.
  • 8Vosseller K, Wells L, Lane MD, Hart GW. Elevated nu- cleocytoplasmic glycosylation by O-GIcNAc results in insulin resistance associated with defects in Aktactiva- tion in 3T3-L1 adipocytes. Proc Natl Acad Sci 2002; 99: 5313-8.
  • 9Yang JY, Gu JL, Shi JH, Liu F, Shen Q. Inhibitory effect of OGT gene expression on the level of tau phosphor- ylation. Jiangsu Daxue Xuebao (Medicine Edition) (in Chinese) 2008; 18: 193-6.
  • 10Vervoorts J, Ltischer-Firzlaff J, Liischer B. The ins and outs of MYC regulation by posttranslational mecha- nisms. J Biol Chem 2006; 281: 34725-9.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部